Women at Increased Risk for Breast Cancer Based on Family History: Calculating Lifetime Risk and Ordering Screening MRI Based on Current U.S. Guidelines

Women at Increased Risk for Breast Cancer Based on Family History: Calculating Lifetime Risk and Ordering Screening MRI Based on Current U.S. Guidelines is organized by International Society of Nurses in Genetics (ISONG).

Start Date: 17 May 2017
End Date: 15 May 2020

Who Should Attend?
This presentation is intended for primary healthcare providers including nurses, nurse practitioners, physician assistants, and physicians who care for women who may be at increased risk for breast cancer.

Accreditation:
ISONG and the University of Pittsburgh School of Nursing are collaborating to provide this learning activity. Nurse participants completing the activity and the evaluation tool will receive one (1) continuing nursing education contact hour. 

Description:
Several organizations recommend healthcare providers offer annual breast MRI to women with lifetime risk for breast cancer above 20%.  In this webinar, Deborah O. Himes and Amanda Gammon will review U.S. breast cancer screening guidelines and risk assessment models. The presenters will provide step-by-step instructions for calculating lifetime risk using the Tyrer-Cuzic model. Additionally, they will present a clinical decision making model to help assess which should  be referred for additional risk assessment and/or referral for genetic counseling.

Objectives:
• During this presentation attendees will learn to calculate lifetime risk for breast cancer using the Tyrer-Cuzick model.
• After this presentation, attendees will be able to explain differences in risk for breast cancer among women in differing risk categories (population, familial, hereditary) and screening guidelines based on risk category (mammography and breast MRI).
• After this presentation attendee will be able to describe three different models used for calculating lifetime risk for breast cancer.
• Following this presentation attendees will understand how to select patients for in-depth risk assessment and/or referral for genetic counseling related to breast cancer risk.